As of 2025-09-19, the EV/EBITDA ratio of Sutro Biopharma Inc (STRO) is -0.06. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. STRO's latest enterprise value is 12.51 mil USD. STRO's TTM EBITDA according to its financial statements is -193.69 mil USD. Dividing these 2 quantities gives us the above STRO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.5x - 15.2x | 13.9x |
| Forward P/E multiples | 13.9x - 22.2x | 19.2x |
| Fair Price | (31.05) - (33.93) | (37.06) |
| Upside | -3539.4% - -3858.3% | -4205.1% |
| Date | EV/EBITDA |
| 2025-09-18 | -0.05 |
| 2025-09-17 | -0.04 |
| 2025-09-16 | -0.06 |
| 2025-09-15 | -0.06 |
| 2025-09-12 | -0.05 |
| 2025-09-11 | -0.09 |
| 2025-09-10 | -0.07 |
| 2025-09-09 | -0.09 |
| 2025-09-08 | -0.10 |
| 2025-09-05 | -0.13 |
| 2025-09-04 | -0.12 |
| 2025-09-03 | -0.11 |
| 2025-09-02 | -0.09 |
| 2025-08-29 | -0.04 |
| 2025-08-28 | -0.06 |
| 2025-08-27 | -0.06 |
| 2025-08-26 | -0.06 |
| 2025-08-25 | -0.04 |
| 2025-08-22 | -0.04 |
| 2025-08-21 | -0.04 |
| 2025-08-20 | -0.05 |
| 2025-08-19 | -0.05 |
| 2025-08-18 | -0.07 |
| 2025-08-15 | -0.05 |
| 2025-08-14 | -0.01 |
| 2025-08-13 | -0.01 |
| 2025-08-12 | -0.01 |
| 2025-08-11 | -0.01 |
| 2025-08-08 | -0.02 |
| 2025-08-07 | -0.02 |
| 2025-08-06 | -0.03 |
| 2025-08-05 | -0.03 |
| 2025-08-04 | -0.03 |
| 2025-08-01 | -0.02 |
| 2025-07-31 | -0.02 |
| 2025-07-30 | -0.05 |
| 2025-07-29 | -0.04 |
| 2025-07-28 | -0.04 |
| 2025-07-25 | -0.06 |
| 2025-07-24 | -0.07 |
| 2025-07-23 | -0.05 |
| 2025-07-22 | -0.04 |
| 2025-07-21 | -0.02 |
| 2025-07-18 | -0.00 |
| 2025-07-17 | -0.00 |
| 2025-07-16 | -0.00 |
| 2025-07-15 | 0.00 |
| 2025-07-14 | -0.00 |
| 2025-07-11 | -0.00 |
| 2025-07-10 | -0.03 |